Vaccines against enteropathogenic Escherichia coli

Revista de Microbiologia

Volumn 27, Issue SUPPL. 1, 1996, Pages 126-129

  Levine, Myron M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343495275     PISSN: 00013714     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Boedeker, E.C.; Chency, C.P. Escherichia coli (strain RDEC-1) diarrhea in the rabbit: An animal model for enteropathogenic E. coli (EPEC) infection of human infants. In: Pfeiffer, CJ. ed. Animal models for intestinal disease, Boca Raton: CRC Press, 1985, p 27-40.
2. Donnenberg, M.S.; Tacket, C.O.; James, S.P.; Losonsky, G.A.; Nataro, J.P.; Wasserman, S.S.; Kaper, J.B.; Levine, M.M. The role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J. Clin. Invest., 92:1412-1417, 1993.
3. Douce, G.; Turcotte, C.; Cropley, I.; Roberts, M.; Pizza, M.; Domenighini, M.; Rappuoli, R.; Dougant, G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyl transferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA. 92:1644-1648, 1995.
4. Dougan, G; Hormaeche, C.; Maskell, D.J. Live oral Salmonella vaccines: potential use of attenuated-strains as carriers of heterologous antigens to the immune system. Parasite Immunol., 9:151-160, 1987.
5. Foubister, V.; Donnenberg, I.; Donnenberg, M.S.; Finlay, B.B. The eaeB gene of enteropathogenic Escherichia coli is necessary for signal transduction in epithelial cells. Infect. Immun., 62:3038-3040, 1994.
6. Frankel, G.; Candy, D.C.A.; Everest, P.; Dougan, G. Characterization of the C-terminal domains of intimin-like proteins of enteropathogenic and enterohemorragic Escherichia coli. Citrobacter freundii, and Hafnia alvei. Infect. Immun., 62:1835-1842, 1994.
7. Girón, J.A.; Ho, A.S.Y.; Schoolnik, G.K. An inducible bundle-forming pilus of enteropathogenic Escherichia coli. Science, 254:710-713, 1991.
8. Girón, J.A.; Xu, J.G.; González, C.R.; Hone, D.M.; Kaper, J.R.; Levine, M.M. Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by aroC, aroD Salmonella typhi vaccine strain CVD 908. Vaccine, 10:939-946, 1995.
9. Gonzalez, C; Hone, D.; Noriega, F.; Tacket, C.O.; Davis, J.R.; Losonsky, G.; Nataro, J.P.; Hoffman, S; Malik, A; Nardin, E; Sztein, M.B.; Heppner, D.G.; Fouts, T.R.; Isibasi, A; Levine, M.M. Salmonella typhi strain-CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction, safety and immunogenicity. J. Infect. Dis., 169:927-931, 1994.
10. Hone, D.M., Harris, A.M.; Chatfield, S.; Dougan, G., Levine, M.M. Construction of genetically defined double mutants of Salmonella typhi. Vaccine. 9:810 816, 1991.
11. Jerse, A.E.: Yu, J; Tall, B.D.; Kaper, J.B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc. Natl. Acad. Sci. USA. 87:7839-7843, 1990.
12. Ketley, J.; Kaper, J.B.; Herrington, D.A.; Losonsky, G.; Levine, M.M. Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD 103. Infect. Immun., 58:1481-1484, 1990.
13. Levine, M.M.; Edelman, R. Enteropathogenic Escherichia coli of classical serotypes associated with infant diarrhea - epidemiology and pathogenesis. Epidemiol. Rev., 6:31-51, 1984.
14. Levine, M.M.; Ferreccio, C.; Prado, V.; Cayazzo, M.; Abrego, P.; Martinez, J.; Maggi, L.; Baldini, M.M.; Martin, W.; Maneval, D.; Kay., B.; Guers, L.; Lior, H.; Wasserman, S.S.; Nataro, J.P. Epidemiologic studies of Escherichia coli diarrheal infections in a low sociocconomic level periurban community in Santiago, Chile. Am. J. Epidemiol., 138:849-869, 1993.
15. Levine, M.M.; Hone, D.; Heppner, D.; Noriega, F.; Sriwathana, B. Attenuated Salmonella as carriers for the expression of foreign antigens. Microecol. Ther., 19:23-32, 1990.
16. Levine, M.M.; Nataro, J.P.; Baldini, M.M.; Kaper, J.B.; Black, R.E.; Clements, M.L.; O'Brien, A.D. The diarrheal response of humans to some classical serotype of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor. J. Infect. Dis., 152:550-559, 1985.
17. Linde, K.; Koch, H.; Untersuchungen zur oralen immunisierung gegen colienteritis mit streptomycin-dependen coli-kemain. Zentralbl. Bakteriol. Parasitent. Infektionskr. Hyg. Abt 1 Orig., 211:476-485, 1969.
18. McQueen, C.E.; Boedeker, E.C.; Reid, R.H.; Jarboe, D.; Wolf, M.; Le, M.; Brown, W.R. Pili in microspheres protect rabbits from diarrhoea-induced by E. coli strain RDEC-1. Vaccine, 11:201-206, 1993.
19. Mochmann, H.; Ocklitz, H.W.; Weh, L.; Heinrich, H. Oral immunization with an extract of Escherichia coli enteritidis. Acta Microbiol. Acad. Sci. Hung., 21:193-196, 1974.
20. Moon, H.W.; Whipp, S.C.; Argenzio, R.A.; Levine, M.M.; Gianella, R.A. Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. Infect. Immun., 41:1340-1351, 1983.
21. Noriega, F.R.; Wang, J.Y.; Losonsky, G; Maneval D.R.; Hone, D.M.; Levine, M.M. Construction and characterization of attenuated aroA virG Shigella flexneri strain CVD 1203, a prototype live vaccine. Infect. Immun., 62:5168-5172, 1995.
22. Noriega, F.R.; Losonsky, G.; Lauderebaugh, C.; Liao, F.M.; Wang, J.Y.; Levine, M.M. Engineered ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine. Infect. Immun., 64:3055-3061, 1996.
23. Noriega, F.R.; Losonsky, G.; Wang, J.Y.; Formal, S.D.; Levine, M.M. Further characterization of ΔguaB-A ΔvirG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live vector for delivering antigens of enterotoxigenic Escherichia coli. Infect Immun., 64:23-27, 1996.
24. Rauss, K.; Ketyi, I.; Matusovilis, E.; Szendrei, L.; Vertenyi, A.; Varbiro, D. Specific oral prevention of infantile enteritis. III. Experiments with corpuscular vaccine. Acta Microbiol. Acad. Sci. Hung., 19:19-28, 1972.
25. Rauss, K.; Ketyi, I.; Szendrai, L.; Vertnyi, A. Immunization of infants against Escherichia coli enteritis. Acta Microbiol. Acad. Sci. Hung., 21:181-185, 1974.
26. Sztein, M.B.; Wasserman, S.S.; Tacket, C.O.; Edelman, R.; Hone D.; Lindberg, A.A.; Levine, M.M. Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J. Infect. Dis., 170:1508-1517, 1994.
27. Tacket, C.O.; Hone, D.M.; Losonsky, G; Guers, L; Edelman, R; Levine, M.M. Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain. Vaccine, 10:443-446, 1992.
28. Takeuchi, A.; Inman, L.R.; O'Hanley O, Cantey, J.R.; Lushbaugh, W.B. Scanning and transmission electron microscopic study of Escherichia coli (RDEC-1) enteric infection in rabbits. Infect. Immun., 19:686-694, 1978.
29. Wolf, M.K.; Andrews, G.P.; Fritz, D.L.; Sjogren-Jr, R.W. Characterization of the plasmid from Escherichia coli RDEC-1 that mediates expression of adhesin AF/R1 and evidence that AF/R1 pili promote but are not essential for enteropathogenic disease. Infect. Immun., 56:1846-1857, 1988.